Last mentioned: Mar 17, 2026
Candel Public Offering
Candel Therapeutics prices $100M public offering at $5.45 per share.
Trial Data Release
Grail shares slide as NHS-Galleri trial misses primary endpoint for late-stage cancer reduction.
GDP Release
U.S. government scheduled to release Q4 GDP growth figures at 8:30 AM ET.
Grail Earnings
Grail reports Q4 and Full Year 2025 financial results, beating revenue and EPS estimates.
BlackRock’s iShares unit has announced quarterly dividend distributions for its broad-market Dow Jones US ETF and its sector-specific US Technology ETF. These payouts reflect the underlying cash flow health of the US equity and technology sectors as of mid-March 2026.
Short interest in the Schwab US Small-Cap ETF (SCHA) has declined by 24.5%, signaling a significant reduction in bearish sentiment. This shift suggests that investors are covering short positions as the risk-reward profile for small-cap equities becomes more attractive.
US equity futures signaled a positive open on Friday as investors shifted focus toward the release of fourth-quarter GDP figures. Following a lackluster Thursday session, the market is looking for confirmation of economic resilience while monitoring individual movers like Grail and Candel Therapeutics.